Rothschild & Co Redburn Boosts CME Group (NASDAQ:CME) Price Target to $333.00

CME Group (NASDAQ:CME) had its target price upped by equities researchers at Rothschild & Co Redburn from $300.00 to $333.00 in a report released on Thursday,MarketScreener reports. The firm presently has a “neutral” rating on the financial services provider’s stock. Rothschild & Co Redburn’s price objective would indicate a potential upside of 9.88% from the company’s current price.

A number of other equities analysts have also recently issued reports on the company. Piper Sandler increased their target price on CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Raymond James Financial dropped their price objective on CME Group from $311.00 to $310.00 and set an “outperform” rating for the company in a research note on Wednesday, February 4th. Morgan Stanley boosted their target price on shares of CME Group from $319.00 to $340.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. The Goldman Sachs Group upped their target price on shares of CME Group from $264.00 to $266.00 and gave the stock a “sell” rating in a report on Monday, February 9th. Finally, Barclays boosted their price target on shares of CME Group from $304.00 to $312.00 and gave the company an “equal weight” rating in a research report on Thursday, February 5th. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, CME Group has an average rating of “Hold” and a consensus target price of $299.53.

CME Group Trading Up 0.5%

Shares of CME stock opened at $303.07 on Thursday. The firm has a fifty day moving average of $279.82 and a 200-day moving average of $274.00. The stock has a market cap of $109.29 billion, a price-to-earnings ratio of 27.16, a P/E/G ratio of 3.28 and a beta of 0.27. CME Group has a 52-week low of $244.43 and a 52-week high of $309.35. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.03.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating the consensus estimate of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period in the previous year, the business earned $2.52 EPS. The firm’s revenue was up 8.1% on a year-over-year basis. On average, equities research analysts forecast that CME Group will post 10.49 earnings per share for the current fiscal year.

Insider Activity at CME Group

In other news, Director William R. Shepard acquired 251 shares of the stock in a transaction that occurred on Tuesday, December 30th. The stock was purchased at an average cost of $278.37 per share, for a total transaction of $69,870.87. Following the completion of the transaction, the director directly owned 258,710 shares in the company, valued at $72,017,102.70. This trade represents a 0.10% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Terrence A. Duffy sold 25,000 shares of the company’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the transaction, the chief executive officer owned 65,804 shares in the company, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by company insiders.

Institutional Trading of CME Group

Institutional investors have recently bought and sold shares of the business. Jessup Wealth Management Inc boosted its position in shares of CME Group by 0.5% in the 2nd quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider’s stock worth $2,197,000 after purchasing an additional 36 shares during the last quarter. First Horizon Advisors Inc. boosted its holdings in CME Group by 0.7% during the second quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock worth $1,453,000 after buying an additional 36 shares during the last quarter. MBM Wealth Consultants LLC boosted its holdings in CME Group by 2.7% during the second quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock worth $392,000 after buying an additional 37 shares during the last quarter. West Family Investments Inc. grew its position in shares of CME Group by 1.2% during the 3rd quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock worth $827,000 after buying an additional 37 shares during the period. Finally, Asset Dedication LLC increased its stake in shares of CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 37 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME raised shareholder payouts — the board declared a Q1 quarterly dividend of $1.30 (up from $1.25) and an annual variable dividend of $6.15 based on 2025 results (total ≈ $2.2B), both payable March 26; that boosts cash return to investors. CME Group Declares Annual Variable Dividend and Q1 2026 Quarterly Dividend
• Positive Sentiment: Analyst price-target lift — Rothschild & Co Redburn raised its CME price target to $333 from $300 (still a “neutral” rating), implying roughly 9.7% upside versus recent levels, which can support buying interest. Rothschild & Co Redburn Adjusts Price Target on CME Group to $333 From $300, Maintains Neutral Rating
• Positive Sentiment: New product rollout and execution — CME reported first trades in new Cardano, Chainlink and Stellar crypto futures and is actively exploring a rare-earths futures contract; these product additions expand fee pools and diversify revenue. CME Group Announces First Trades for New Cardano, Chainlink and Stellar Cryptocurrency Futures CME Weighs Launching First-Ever Rare Earth Futures Contract / Reuters
• Positive Sentiment: Asia expansion — reports say CME plans to list Taiwan and Hong Kong warehouses for aluminium futures in Asia, a move that could deepen regional market presence and increase volumes. Exclusive: CME to list Taiwan, Hong Kong warehouses in Asia aluminium push, sources say
• Neutral Sentiment: CFTC advisory involvement — the CFTC formed an Innovation Advisory Committee that includes a CME executive; this provides regulatory engagement but unclear near-term financial impact. CFTC Forms Innovation Advisory Committee With 35 Crypto and Finance Industry Leaders
• Neutral Sentiment: Board slate announced — CME named director nominees for the annual meeting; routine governance news that is unlikely to move the stock materially. CME Group Inc. Names Slate of Director Nominees
• Neutral Sentiment: Analyst/earnings commentary — recent analyst-question coverage from the Q4 call provides context for growth drivers but contains no new guidance. 5 Must-Read Analyst Questions From CME Group’s Q4 Earnings Call
• Negative Sentiment: Short-interest reporting is inconsistent — filings flagged a “significant increase” in February short interest but published data show zeros/NaN, creating ambiguity; if short interest is actually rising, that could add downward pressure.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.